Papers in this category present clinical research that has a clear potential to optimize patient care, with particular emphasis on high quality randomized controlled trials, novel combination treatments, therapies, novel diagnostic or prognostic insights and new insights into mechanism of action.
Shailender Bhatia, MD
University of Washington
"Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase I/II study"
Shailender Bhatia, Brendan Curti, Marc S. Ernstoff, Michael Gordon, Elisabeth I. Heath, Wilson H. Miller Jr., Igor Puzanov, David I. Quinn, Thomas W. Flaig, Peter VanVeldhuizen, Kelly Byrnes-Blake, Jeremy A. Freeman, Rachel Bittner, Naomi Hunder, Sonia Souza and John A. Thompson
Journal for ImmunoTherapy of Cancer 2014 2:2